Diabetes Drugs Market Size, Share, Growth & Industry Analysis, By Drug Class (Insulin, GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, Sulfonylureas, Others), By Drug Type (Oral Drugs, Injectable Drugs), By End-User (Hospitals, Homecare, Clinics, Others), and Regional Analysis, 2024-2031

1 INTRODUCTION OF THE GLOBAL DIABETES DRUGS MARKET
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL DIABETES DRUGS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL DIABETES DRUGS MARKET, BY DRUG CLASS
6.1 Overview
6.2 Insulin
6.3 GLP-1 Receptor Agonists
6.4 SGLT2 Inhibitors
6.5 DPP-4 Inhibitors
6.6 Sulfonylureas
6.7 Others

7 GLOBAL DIABETES DRUGS MARKET, BY DRUG TYPE
7.1 Overview
7.2 Oral Drugs
7.3 Injectable Drugs

8 GLOBAL DIABETES DRUGS MARKET, BY END-USER
8.1 Overview
8.2 Hospitals
8.3 Homecare
8.4 Clinics
8.5 Others

9 GLOBAL DIABETES DRUGS MARKET, BY GEOGRAPHY
9.1 Overview

10 NORTH AMERICA
10.1 U.S.
10.2 Canada
10.3 Mexico

11 EUROPE
11.1 Germany
11.2 UK
11.3 France
11.4 Italy
11.5 Spain
11.6 Russia
11.7 Rest of Europe

12 ASIA-PACIFIC
12.1 China
12.2 Japan
12.3 India
12.4 South Korea
12.5 Rest of Asia-Pacific

13 MIDDLE EAST & AFRICA
13.1 GCC
13.2 South Africa
13.3 North Africa
13.4 Rest of Middle East & Africa

14 LATIN AMERICA
14.1 Brazil
14.2 Argentina
14.3 Rest of South America

15 GLOBAL DIABETES DRUGS MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Industry Footprint

16 COMPANY PROFILES
16.1 Novo Nordisk
16.1.1 Key Facts
16.1.2 Financial Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.1.5 Winning Imperatives
16.1.6 Current Focus & Strategies
16.1.7 Threat from competition
16.1.8 SWOT Analysis
16.2 Sanofi
16.2.1 Key Facts
16.2.2 Financial Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.2.5 Winning Imperatives
16.2.6 Current Focus & Strategies
16.2.7 Threat from competition
16.2.8 SWOT Analysis
16.3 Eli Lilly
16.3.1 Key Facts
16.3.2 Financial Overview
16.3.3 Product Benchmarking
16.3.4 Recent Developments
16.3.5 Winning Imperatives
16.3.6 Current Focus & Strategies
16.3.7 Threat from competition
16.3.8 SWOT Analysis
16.4 Merck & Co.
16.4.1 Key Facts
16.4.2 Financial Overview
16.4.3 Product Benchmarking
16.4.4 Recent Developments
16.4.5 Winning Imperatives
16.4.6 Current Focus & Strategies
16.4.7 Threat from competition
16.4.8 SWOT Analysis
16.5 AstraZeneca
16.5.1 Key Facts
16.5.2 Financial Overview
16.5.3 Product Benchmarking
16.5.4 Recent Developments
16.5.5 Winning Imperatives
16.5.6 Current Focus & Strategies
16.5.7 Threat from competition
16.5.8 SWOT Analysis
16.6 Boehringer Ingelheim
16.6.1 Key Facts
16.6.2 Financial Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.7 Bristol-Myers Squibb
16.7.1 Key Facts
16.7.2 Financial Overview
16.7.3 Product Benchmarking
16.7.4 Recent Developments
16.8 Johnson & Johnson
16.8.1 Key Facts
16.8.2 Financial Overview
16.8.3 Product Benchmarking
16.8.4 Recent Developments
16.9 GlaxoSmithKline
16.9.1 Key Facts
16.9.2 Financial Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments
16.10 Novartis
16.10.1 Key Facts
16.10.2 Financial Overview
16.10.3 Product Benchmarking
16.10.4 Recent Developments

LIST OF TABLES

TABLE 1 Global Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 2 Global Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 3 Global Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 4 Global Diabetes Drugs Market Revenue, By Geography, 2021 – 2031 (USD Billion)
TABLE 5 North America Diabetes Drugs Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 6 North America Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 7 North America Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 8 North America Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 9 US Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 10 US Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 11 US Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 12 Canada Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 13 Canada Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 14 Canada Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 15 Mexico Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 16 Mexico Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 17 Mexico Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 18 Europe Diabetes Drugs Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 19 Europe Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 20 Europe Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 21 Europe Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 22 Germany Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 23 Germany Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 24 Germany Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 25 France Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 26 France Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 27 France Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 28 UK Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 29 UK Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 30 UK Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 31 Spain Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 32 Spain Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 33 Spain Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 34 Italy Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 35 Italy Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 36 Italy Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 37 Russia Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 38 Russia Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 39 Russia Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 40 Rest of Europe Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 41 Rest of Europe Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 42 Rest of Europe Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 43 Asia-Pacific Diabetes Drugs Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 44 Asia-Pacific Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 45 Asia-Pacific Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 46 Asia-Pacific Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 47 China Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 48 China Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 49 China Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 50 Japan Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 51 Japan Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 52 Japan Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 53 India Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 54 India Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 55 India Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 56 South Korea Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 57 South Korea Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 58 South Korea Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 59 Rest of Asia-Pacific Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 60 Rest of Asia-Pacific Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 61 Rest of Asia-Pacific Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 62 Middle East and Africa Diabetes Drugs Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 63 Middle East and Africa Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 64 Middle East and Africa Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 65 Middle East and Africa Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 66 GCC Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 67 GCC Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 68 GCC Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 69 North Africa Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 70 North Africa Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 71 North Africa Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 72 South Africa Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 73 South Africa Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 74 South Africa Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 75 Rest of Middle East & Africa Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 76 Rest of Middle East & Africa Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 77 Rest of Middle East & Africa Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 78 Latin America Diabetes Drugs Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 79 Latin America Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 80 Latin America Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 81 Latin America Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 82 Brazil Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 83 Brazil Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 84 Brazil Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 85 Argentina Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 86 Argentina Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 87 Argentina Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 88 Rest of Latin America Diabetes Drugs Market Revenue, By Drug Class, 2021 – 2031 (USD Billion)
TABLE 89 Rest of Latin America Diabetes Drugs Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 90 Rest of Latin America Diabetes Drugs Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 91 Company Market Ranking
TABLE 92 Regional Footprint
TABLE 93 Product Benchmarking
TABLE 94 Recent Developments
TABLE 95 Winning Imperatives

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Diabetes Drugs Market 2021-2031 (USD Billion)
FIG. 4 Global Diabetes Drugs Market Geographical Analysis (CAGR %)
FIG. 5 Global Diabetes Drugs Absolute Market Opportunity (USD Billion)
FIG. 6 Global Diabetes Drugs Market Attractiveness (USD Billion)
FIG. 7 Global Diabetes Drugs Market, By Drug Class, 2021-2031 (USD Billion)
FIG. 8 Global Diabetes Drugs Market, By Drug Type, 2021-2031 (USD Billion)
FIG. 9 Global Diabetes Drugs Market, By End-User, 2021-2031 (USD Billion)
FIG. 11 Research Methodology
FIG. 12 Research Process
FIG. 13 Bottom-Up Approach
FIG. 14 Top-Bottom Approach
FIG. 15 Market Dynamics Overview
FIG. 16 Porter's Five Forces Analysis
FIG. 17 Value Chain Analysis
FIG. 18 Macroeconomic Analysis
FIG. 19 Global Diabetes Drugs Market Revenue Share, By Drug Class, 2021 and 2031 (%)
FIG. 20 Global Diabetes Drugs Market Revenue Share, By Drug Type, 2021 and 2031 (%)
FIG. 21 Global Diabetes Drugs Market Revenue Share, By End-User, 2021 and 2031 (%)
FIG. 22 Global Diabetes Drugs Market Revenue Share, By Geographic Regions, 2021 and 2031 (%)
FIG. 23 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 24 North America Diabetes Drugs Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 25 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 26 Europe Diabetes Drugs Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 27 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 28 Asia-Pacific Diabetes Drugs Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 29 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 30 Middle East & Africa Diabetes Drugs Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 31 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 32 Latin America Diabetes Drugs Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 33 Key Strategic Development
FIG. 34 Key Facts
FIG. 35 Financial Overview
FIG. 36 SWOT Analysis